Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer
Clinical trial NCT03171025 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03171025
- Sponsor
- University of Utah
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-10
- Primary completion
- 2025-02-10
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.